Downgraded from 7 to 5. Active asset manager with structural headwinds from passive investing shift. 11% analyst upside is modest, DCF stale. Fee compression secular trend working against thesis. No compelling catalyst. "Good company" is not an edge — this is a melting ice cube.
10-Q confirms thesis ahead of schedule. Was 6 (WAM tail risk limited view), now 7: risk crystallizing as manageable, not existential. DOJ non-criminal + CFTC closed = firm survives. AUM +7% YoY, flows positive, margins at target, adjusted EPS +19% YoY. Moving to 7 vs 8 because SEC investigation still open and class actions early stage.
Fair Value Distribution — percentile bands
0.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
13.4%/yr
±4.2% · revenue growth to justify current price
FCF-Based Reverse DCF
16.7%/yr
±3.1% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Eagle will generate this view by the next trading session (~6h).
Eagle will generate this view by the next trading session (~6h).
Adjusted margin hits exactly 25% thesis target. Net flows turned positive (+$26.8B) — first meaningful inflection in years. WAM DOJ heading to non-criminal resolution (CFTC closed). EPS +19% YoY on ad...
BEN: margin-accretive Q1 on AUM scale, but WAM scandal clouds growth outlook. Fixed income headwinds. Fair value ~$28-32 on base case, depends on litigation resolution.